Putting meat on the bone: how to fast-track innovative medicines to those who need them and generate data to justify continued use
Health Affairs Scholar · 02.08.2024 · 2 (8)
DOI: 10.1093/haschl/qxae095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs Scholar, online erschienen am 09.08.2024. Verfasst von Daniel Ollendorf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA 02111, United States. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bellberry Ltd, Amgen, AstraZeneca.
Abstract (Originalsprache)
Regulatory agencies worldwide have taken significant steps to expedite approval and market authorization of medicines based on their potential to address areas of significant unmet medical need and severe disease burden. However, initial approval of such medicines is often accompanied by limited evidence of benefit, posing a conundrum for payers and health systems who may desire greater certainty of their value. This paper describes a system of “accelerated access” to manage these tensions and coordinate activities across stakeholders, based on discussions held at a multi-stakeholder convening in June 2023. We focus on 6 core, near-term actions that can be taken to improve the current system: clarifying criteria for expedited regulatory approval, enhancing stakeholder coordination, creating expedited pathways in payer and health technology assessment settings, developing joint regulatory/payer/health technology assessment guidance on study design and data needs, linking pricing policy to data uncertainty, and improving patient and public understanding of the processes involved as well as the risks and benefits of the relevant medicines. Many of these actions will require additional resources and personnel, and some will necessitate unprecedented levels of coordination. Nevertheless, each action is designed to work with minimal adjustments to the current system rather than demanding an entirely new approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA 02111, United States.
- Institute for Clinical and Economic Review, Boston, MA 02108, United States.
- Office of Health Economics, London SE1 2HB, United Kingdom.
- University of South Australia, Kent Town, South Australia 5071, Australia.
- Rubix Health, LLC, Baltimore, MD 21210, United States.
ORCID-Profile: Daniel Ollendorf, Marie Phillips, Patricia Synnott, Lloyd Sansom, Sean Tunis
Förderung
- Bellberry Ltd
- Amgen
- AstraZeneca
- Johnson & Johnson
- Merck, Sharp & Dohme
Zitieren
APA
Ollendorf, D., Henshall, C., Phillips, M., Synnott, P., Sansom, L., & Tunis, S. (2024). Putting meat on the bone: how to fast-track innovative medicines to those who need them and generate data to justify continued use. Health Affairs Scholar, 2(8). https://doi.org/10.1093/haschl/qxae095
Vancouver
Ollendorf D, Henshall C, Phillips M, Synnott P, Sansom L, Tunis S. Putting meat on the bone: how to fast-track innovative medicines to those who need them and generate data to justify continued use. Health Affairs Scholar. 2024;2(8). doi:10.1093/haschl/qxae095
BibTeX
@article{Ollendorf2024,
author = {Ollendorf, Daniel and Henshall, Christopher and Phillips, Marie and Synnott, Patricia and Sansom, Lloyd and Tunis, Sean},
title = {Putting meat on the bone: how to fast-track innovative medicines to those who need them and generate data to justify continued use},
journal = {Health Affairs Scholar},
year = {2024},
volume = {2},
number = {8},
doi = {10.1093/haschl/qxae095}
}
EUVIMED